mr 2034 has been researched along with chlornaltrexamine in 1 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (chlornaltrexamine) | Trials (chlornaltrexamine) | Recent Studies (post-2010) (chlornaltrexamine) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 78 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akil, H; Houghten, RA; Lewis, ME; Walker, JM; Woods, JH; Young, EA | 1 |
1 other study(ies) available for mr 2034 and chlornaltrexamine
| Article | Year |
|---|---|
[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
Topics: Alkylating Agents; Animals; Benzomorphans; Brain Chemistry; Dynorphins; Guinea Pigs; In Vitro Techniques; Macaca mulatta; Morphine; Naltrexone; Peptides; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism | 1986 |